Overview
Revograf tablets are indicated for the prophylaxis of acute organ rejection and for the treatment of refractory organ rejection in patients receiving allogeneic renal transplants. Revograf tablets are indicated for the prophylaxis of acute organ rejection and increased graft and patient survival in patients receiving allogeneic cardiac transplants. Revograf is indicated for the prophylaxis of acute organ rejection in patients receiving allogeneic hepatic transplants. Revograf should be used concomitantly with cyclosporin and corticosteroids